Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Prostate Cancer
100%
American Society of Clinical Oncology
100%
Prostate-specific Antigen Testing
100%
Clinical Opinion
100%
Life Expectancy
66%
Randomized Trial
33%
Prostate Biopsy
33%
Calculator
33%
Strength of Evidence
33%
Strength of Recommendation
33%
United States
16%
Adverse Events
16%
Rate of Increase
16%
Population-based Study
16%
Cancer Mortality
16%
Prostate Cancer Screening
16%
Prostate-specific Antigen
16%
Radiation Therapy
16%
Early Detection
16%
Evidence-based
16%
Mortality Rate
16%
Clinical Setting
16%
Risk of Bias
16%
Intermediate Risk
16%
Treatment Efficacy
16%
Evidence-based Data
16%
Expert Opinion
16%
Cancer Causes
16%
Risk of Death
16%
Quality of Health Care
16%
Healthcare Research
16%
Existing Data
16%
Infectious Complications
16%
Surgery Treatment
16%
Indirect Data
16%
Unnecessary Biopsy
16%
Public Domain
16%
Practice Changing
16%
Lay Language
16%
Inconsistent Results
16%
Medicine and Dentistry
Prostate Specific Antigen
100%
Prostate Cancer
100%
Clinical Oncology
100%
Life Expectancy
57%
Prostate Biopsy
28%
Adverse Event
14%
Cancer Mortality
14%
Clinician
14%
Mortality Rate
14%
Randomized Controlled Trial
14%
Systematic Review
14%
Infectious Complication
14%
Quality of Health Care
14%
Biopsy Technique
14%
Healthcare Research
14%
Cancer Screening
14%
Radiation Therapy
14%
Radiation Treatment
14%
Cohort Studies
14%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Prostate Specific Antigen
100%
Life Expectancy
57%
Cohort Study
14%
Adverse Event
14%
Cancer Mortality
14%
Mortality Rate
14%
Randomized Controlled Trial
14%
Infectious Complication
14%